Proactive Investors
14 May 2026, 12:53 UTC · 21w ago
Verdict
Headline leans bullish. We score BHST +0.60 across five claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
More positive than 75% of ticker scores this week
Search tags
What the story claims
5 claims · scored −1 bearish … +1 bullish
BioHarvest's CDMO business recorded 135% year-over-year revenue growth in the first quarter.
More positive than 98% of claims this week
BioHarvest signed over $2 million in combined Stage 2 development agreements for fragrance and saffron botanical synthesis programs.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 93% of claims this week
The company maintained its full-year revenue guidance range of $42 million to $48 million.
More positive than 87% of claims this week
Net loss for the quarter widened to $2.6 million, or $0.11 per diluted share, from $2.3 million, or $0.13 per diluted share, a year earlier.
So whatIncreasing net losses indicate ongoing cash burn and operational unprofitability, pressuring the company's bottom line despite top-line growth.
More negative than 86% of claims this week
A new manufacturing site is expected to become operational in the second half of 2027.
More positive than 65% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
The company reported an 8% increase in Q1 revenue, 135% growth in its CDMO business, and successfully advanced two major development programs.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
−62.6%
Price is moving against the score
$1.50 vs $4.01 close before publication (May 13) · not market-adjusted
BHST chart →
